---
layout: post
title: "数说A股：医药股霸占人气榜前三 中国医药拔得头筹！6连板浙江建投关注度仍居高位"
date: 2022-05-07 16:29:55 +0800
categories: emnews
tags: 东财滚动新闻
---
> 截止今日发稿，医药股霸占人气榜前三甲，中国医药拔得头筹，精华制药、双成药业紧随其后。浙江建投、海南发展、美利云、爱旭股份、宏润建设、海康威视、徐家汇等也榜上有名。

<p>五一假期归来，本周A股仅有两个交易日。首日，沪深主板指数迎来“开门红”之后，昨日A股又惨遭美股拖累，三大股指全天在水下震荡，尽管盘中一度有反抽表现，但不改整体弱势，最终三大股指全线收跌。</p><p><span id="stock_1.601788"><a href="http://quote.eastmoney.com/unify/r/1.601788" class="keytip" data-code="1,601788">光大证券</a></span><span id="quote_1.601788"></span>表示，当前市场估值处于底部水平，如果仅考虑过去两年的短周期情况，目前估值分位数已经接近最低水平。不过从其他指标，例如流动性或者自下而上估值较低的个股占比来看，市场仍高于历史底部位置。</p><p>那么，本周有哪些股穿越牛熊？又有哪些股票登上人气榜？下周投资者应该做什么准备？通过数据或许可以窥见一二。</p><p><strong>注意了！</strong></p><p><strong>3</strong><strong>只破发股、5</strong><strong>只破净股连涨5</strong><strong>天</strong></p><p>截止今日(5月7日)发稿，根据<span id="stock_0.300059"><a href="http://quote.eastmoney.com/unify/r/0.300059" class="keytip" data-code="0,300059">东方财富</a></span><span id="quote_0.300059"></span><span id="Info.3251"><a href="http://choice.eastmoney.com/?adid=2804" class="infokey">Choice数据</a></span>显示，<span id="stock_0.000039"><a href="http://quote.eastmoney.com/unify/r/0.000039" class="keytip" data-code="0,000039">中集集团</a></span><span id="quote_0.000039"></span>、<span id="stock_1.600780"><a href="http://quote.eastmoney.com/unify/r/1.600780" class="keytip" data-code="1,600780">通宝能源</a></span><span id="quote_1.600780"></span>、<span id="stock_0.002298"><a href="http://quote.eastmoney.com/unify/r/0.002298" class="keytip" data-code="0,002298">中电兴发</a></span><span id="quote_0.002298"></span>、<span id="stock_1.603003"><a href="http://quote.eastmoney.com/unify/r/1.603003" class="keytip" data-code="1,603003">龙宇燃油</a></span><span id="quote_1.603003"></span>、<span id="stock_1.600969"><a href="http://quote.eastmoney.com/unify/r/1.600969" class="keytip" data-code="1,600969">郴电国际</a></span><span id="quote_1.600969"></span>等5只破净股连涨5天以上(含5天)。另外，<span id="stock_1.688236"><a href="http://quote.eastmoney.com/unify/r/1.688236" class="keytip" data-code="1,688236">春立医疗</a></span><span id="quote_1.688236"></span>、<span id="stock_0.301216"><a href="http://quote.eastmoney.com/unify/r/0.301216" class="keytip" data-code="0,301216">万凯新材</a></span><span id="quote_0.301216"></span>、<span id="stock_1.688283"><a href="http://quote.eastmoney.com/unify/r/1.688283" class="keytip" data-code="1,688283">坤恒顺维</a></span><span id="quote_1.688283"></span>等3只破发股连涨5天以上(含5天)。</p><center><img src="https://dfscdn.dfcfw.com/download/D25434411526447409822_w377h165.jpg" width="580" orginial_src="https://dfscdn.dfcfw.com/download/D25434411526447409822_w377h165_o.jpg" style="border:#d1d1d1 1px solid;padding:3px;margin:5px 0;" /></center><center><img src="https://dfscdn.dfcfw.com/download/D25125950782653049438_w349h259.jpg" width="580" orginial_src="https://dfscdn.dfcfw.com/download/D25125950782653049438_w349h259_o.jpg" style="border:#d1d1d1 1px solid;padding:3px;margin:5px 0;" /></center><p><strong>医药股霸占人气榜前三</strong></p><p><strong><span id="stock_1.600056"><a href="http://quote.eastmoney.com/unify/r/1.600056" class="keytip" data-code="1,600056">中国医药</a></span><span id="quote_1.600056"></span>拔得头筹！</strong></p><p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/sh600056.html" data-code="600056|1|1" data-code2="600056|1|2|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.600056&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 600056_0" data-code="K 600056|1|1" data-code2="K 600056|1|2|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>截止今日发稿，医药股霸占人气榜前三甲，<span web="1" href="http://quote.eastmoney.com/unify/r/1.600056" class="em_stock_key_common" data-code="1,600056">中国医药</span>拔得头筹，<span id="stock_0.002349"><a href="http://quote.eastmoney.com/unify/r/0.002349" class="keytip" data-code="0,002349">精华制药</a></span><span id="quote_0.002349"></span>、<span id="stock_0.002693"><a href="http://quote.eastmoney.com/unify/r/0.002693" class="keytip" data-code="0,002693">双成药业</a></span><span id="quote_0.002693"></span>紧随其后。<span id="stock_0.002761"><a href="http://quote.eastmoney.com/unify/r/0.002761" class="keytip" data-code="0,002761">浙江建投</a></span><span id="quote_0.002761"></span>、<span id="stock_0.002163"><a href="http://quote.eastmoney.com/unify/r/0.002163" class="keytip" data-code="0,002163">海南发展</a></span><span id="quote_0.002163"></span>、<span id="stock_0.000815"><a href="http://quote.eastmoney.com/unify/r/0.000815" class="keytip" data-code="0,000815">美利云</a></span><span id="quote_0.000815"></span>、<span id="stock_1.600732"><a href="http://quote.eastmoney.com/unify/r/1.600732" class="keytip" data-code="1,600732">爱旭股份</a></span><span id="quote_1.600732"></span>、<span id="stock_0.002062"><a href="http://quote.eastmoney.com/unify/r/0.002062" class="keytip" data-code="0,002062">宏润建设</a></span><span id="quote_0.002062"></span>、<span id="stock_0.002415"><a href="http://quote.eastmoney.com/unify/r/0.002415" class="keytip" data-code="0,002415">海康威视</a></span><span id="quote_0.002415"></span>、<span id="stock_0.002561"><a href="http://quote.eastmoney.com/unify/r/0.002561" class="keytip" data-code="0,002561">徐家汇</a></span><span id="quote_0.002561"></span>等也榜上有名。</p><center><strong><img src="https://dfscdn.dfcfw.com/download/D25468848722871514516_w1280h3412.jpg" width="580" orginial_src="https://dfscdn.dfcfw.com/download/D25468848722871514516_w1280h3412_o.jpg" style="border:1px solid #d1d1d1;padding:3px;margin:5px 0px;width:580px;height:1546px;float:none;" height="1546" border="0" hspace="0" vspace="0" /></strong></center><p><strong>关注度居高不下</strong></p><p><strong><span web="1" href="http://quote.eastmoney.com/unify/r/0.002761" class="em_stock_key_common" data-code="0,002761">浙江建投</span>6</strong><strong>连板风头正劲！</strong></p><p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/sz002761.html" data-code="002761|0|2" data-code2="002761|0|6|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=0.002761&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 002761_0" data-code="K 002761|0|2" data-code2="K 002761|0|6|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>根据东财关注指数来看，<span web="1" href="http://quote.eastmoney.com/unify/r/0.002761" class="em_stock_key_common" data-code="0,002761">浙江建投</span>6连板风头正劲，市场关注度居高不下。此外、<span id="stock_0.002432"><a href="http://quote.eastmoney.com/unify/r/0.002432" class="keytip" data-code="0,002432">九安医疗</a></span><span id="quote_0.002432"></span>、<span id="stock_0.300750"><a href="http://quote.eastmoney.com/unify/r/0.300750" class="keytip" data-code="0,300750">宁德时代</a></span><span id="quote_0.300750"></span>、<span id="stock_0.000625"><a href="http://quote.eastmoney.com/unify/r/0.000625" class="keytip" data-code="0,000625">长安汽车</a></span><span id="quote_0.000625"></span>等热门股也备受关注。(关注指数：根据股吧浏览、自选股添加等数据统计得出，关注指数越高代表该股越受市场关注)<br /></p><center><img src="https://dfscdn.dfcfw.com/download/D24795118030706835983_w538h577.jpg" width="580" orginial_src="https://dfscdn.dfcfw.com/download/D24795118030706835983_w538h577_o.jpg" style="border:1px solid #d1d1d1;padding:3px;margin:5px 0px;width:580px;height:624px;float:none;" height="624" border="0" hspace="0" vspace="0" /></center><p><strong>下周一<span id="Info.325"><a href="http://data.eastmoney.com/dxf/default.html" class="infokey">解禁股</a></span>名单来了</strong></p><p><strong><span id="stock_1.603259"><a href="http://quote.eastmoney.com/unify/r/1.603259" class="keytip" data-code="1,603259">药明康德</a></span><span id="quote_1.603259"></span>榜上有名！</strong></p><p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/sh603259.html" data-code="603259|1|1" data-code2="603259|1|2|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.603259&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 603259_0" data-code="K 603259|1|1" data-code2="K 603259|1|2|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>下周一将有26只股解禁。据悉，其中<span web="1" href="http://quote.eastmoney.com/unify/r/1.603259" class="em_stock_key_common" data-code="1,603259">药明康德</span>分别将在5月9日和12日解禁16.66万股和378.61万股。另外，<span id="stock_1.601611"><a href="http://quote.eastmoney.com/unify/r/1.601611" class="keytip" data-code="1,601611">中国核建</a></span><span id="quote_1.601611"></span>、<span id="stock_1.600809"><a href="http://quote.eastmoney.com/unify/r/1.600809" class="keytip" data-code="1,600809">山西汾酒</a></span><span id="quote_1.600809"></span>、<span id="stock_1.603185"><a href="http://quote.eastmoney.com/unify/r/1.603185" class="keytip" data-code="1,603185">上机数控</a></span><span id="quote_1.603185"></span>等标的也面临解禁。根据一季报<span id="Info.3321"><a href="http://data.eastmoney.com/bbsj/" class="infokey">业绩</a></span>来看，<span web="1" href="http://quote.eastmoney.com/unify/r/1.600809" class="em_stock_key_common" data-code="1,600809">山西汾酒</span>的盈利最高，一季度实现<span id="Info.3323"><a href="http://data.eastmoney.com/bbsj/" class="infokey">营业收入</a></span>105.3亿元，同比增长43.62%；<span id="Info.3324"><a href="http://data.eastmoney.com/bbsj/" class="infokey">净利润</a></span>37.1亿元，同比增长70.03%。<br /></p><center><strong><img src="https://dfscdn.dfcfw.com/download/D24715202248346958599_w433h1432.jpg" width="580" emheight="1432" orginial_src="https://dfscdn.dfcfw.com/download/D24715202248346958599_w433h1432_o.jpg" style="border:1px solid #d1d1d1;padding:3px;margin:5px 0px;width:580px;height:1933px;float:none;" height="1933" border="0" hspace="0" vspace="0" /></strong></center><p class="em_media">（文章来源：<span web="1" href="http://quote.eastmoney.com/unify/r/0.300059" class="em_stock_key_common" data-code="0,300059">东方财富</span>研究中心）</p>

<http://stock.eastmoney.com/news/1405,202205072371526236.html>

[返回东财滚动新闻](//finews.withounder.com/emnews/)｜[返回首页](//finews.withounder.com/)